U.S. Public Health Service Task Force Recommendations for the Use of Antiretroviral Drugs in Pregnant Women Infected with HIV-1 for Maternal Health and for Reducing Perinatal HIV-1 Transmission in the United StatesJean Anderson, Cheryl Thiemann, Nancy A. Wade et al.|Unknown|2000Cited by 104
Maternal toxicity and pregnancy complications in human immunodeficiency virus–infected women receiving antiretroviral therapy: PACTG 316D. Heather Watts, Coleen K. Cunningham, Rajalakshmi Balasubramanian et al.|American Journal of Obstetrics and Gynecology|2004Cited by 99
Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudineJohn S. Lambert, Mary Glenn Fowler, D. Heather Watts et al.|AIDS|2000Cited by 80
Effect of Cessation of Zidovudine Prophylaxis to Reduce Vertical Transmission on Maternal HIV Disease Progression and SurvivalArlene Bardeguez, Mary Jo O’Sullivan, David E. Shapiro et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2003Cited by 44